Zobrazeno 1 - 10
of 638
pro vyhledávání: '"Gamerith, G."'
Autor:
Mildner, F.O., Sykora, M.M., Hackl, H., Amann, A., Zelger, B., Sprung, S., Buch, M.L., Nocera, F., Moser, P., Maier, H., Augustin, F., Manzl, C., Kocher, F., Pircher, A., Lindenmann, J., Mykoliuk, I, Raftopoulou, S., Kargl, J., Wolf, D., Sopper, S., Gamerith, G.
Publikováno v:
In Lung Cancer October 2024 196
Autor:
Nocera, F.I., Mildner, F., Kelm, J.M., Freitas, M., Nikitina, K., Manser, S., Sopper, S., Gamerith, G., Seeber, A., Amann, A.
Publikováno v:
In Immuno-Oncology and Technology December 2023 20 Supplement
Autor:
Fuereder, T., Klinghammer, K., Hahn, D.A., Grünberger, B., Melchardt, T., Greil, R., Kocher, F., Gamerith, G., Wagner, C., Berchtold, L., Burian, M., Strobl, A.
Publikováno v:
In Annals of Oncology September 2024 35 Supplement 2:S629-S629
Autor:
Koeck S; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria., Amann A; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria., Kern J; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.; Department of Otorhinolaryngology, Head and Neck Surgery, Mannheim Medical Faculty of Heidelberg University, Mannheim, Germany., Zwierzina M; Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Innsbruck, Innsbruck, Austria., Lorenz E; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria., Sopper S; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria., Zwierzina H; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria., Mildner F; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria., Sykora M; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria., Sprung S; Department of Pathology, Neuropathology, and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Tyrol, Austria., Hackl H; Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Tyrol, Austria., Augustin F; Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Medical University of Innsbruck, Innsbruck, Tyrol, Austria., Maier HT; Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Medical University of Innsbruck, Innsbruck, Tyrol, Austria., Pircher A; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria., Pall G; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria., Wolf D; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria., Gamerith G; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2023 Nov 28; Vol. 12 (1), pp. 2274130. Date of Electronic Publication: 2023 Nov 28 (Print Publication: 2023).
Autor:
Lee, H.J., Jeong, G., Li, H., Kim, M., Kim, J., Park, S.J., Han, Y.J., Lee, K.H., Kronbichler, A., Hong, S.H., Ghayda, R.A., Luchini, C., Nottegar, A., Koyanagi, A., Smith, L., Jacob, L., Dragioti, E., Radua, J., Cargnin, S., Terrazzino, S., Thompson, T., Yon, D.K., Lee, S.W., Yang, J.M., Wasuwanich, P., Shin, J.L., Gamerith, G.
OBJECTIVE: It is controversial whether there is efficacy or safety benefit of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) in advanced EGFR-mutated non-small cell lung cancer (NSCLC) compared to standard chemotherapy. We aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c28ef085067790fba186e02ec094bb69
https://arro.anglia.ac.uk/id/eprint/706477/5/Lee_et_al_2021.pdf
https://arro.anglia.ac.uk/id/eprint/706477/5/Lee_et_al_2021.pdf
Autor:
Wagner SM; III Medical Department at the Paracelsus Medical University, Salzburg, Austria.; Salzburg Cancer Research Institute, Salzburg, Austria., Magnes T; III Medical Department at the Paracelsus Medical University, Salzburg, Austria.; Salzburg Cancer Research Institute, Salzburg, Austria., Melchardt T; III Medical Department at the Paracelsus Medical University, Salzburg, Austria.; Salzburg Cancer Research Institute, Salzburg, Austria., Kiem D; III Medical Department at the Paracelsus Medical University, Salzburg, Austria.; Salzburg Cancer Research Institute, Salzburg, Austria., Weiss L; III Medical Department at the Paracelsus Medical University, Salzburg, Austria.; Salzburg Cancer Research Institute, Salzburg, Austria., Neureiter D; Institute of Pathology, Paracelsus Medical University, Salzburg, Austria., Wagner C; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Aretin MB; Department of Pharmacy, Medical University of Vienna, Vienna, Austria., Nemec S; Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria., Gamerith G; Department of Internal Medicine V (Hematology and Oncology), Medical University of Innsbruck, Innsbruck, Austria., Pall G; Department of Internal Medicine V (Hematology and Oncology), Medical University of Innsbruck, Innsbruck, Austria., Greil R; III Medical Department at the Paracelsus Medical University, Salzburg, Austria; r.greil@salk.at.; Salzburg Cancer Research Institute, Salzburg, Austria., Fuereder T; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Publikováno v:
Anticancer research [Anticancer Res] 2023 Mar; Vol. 43 (3), pp. 1273-1282.
Autor:
Lee KH, Seong HJ, Kim G, Jeong GH, Kim JY, Park H, Jung E, Kronbichler A, Eisenhut M, Stubbs B, Solmi M, Koyanagi A, Hong SH, Dragioti E, de Rezende LFM, Jacob L, Keum N, van der Vliet HJ, Cho E, Veronese N, Grosso G, Ogino S, Song M, Radua J, Jung SJ, Thompson T, Jackson SE, Smith L, Yang L, Hans Oh, Choi EK, Shin JI, Giovannucci EL, Gamerith G
Publikováno v:
ADV NUTR
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Multiple studies have suggested that ?-3 fatty acid intake may have a protective effect on cancer risk; however, its true association with cancer risk remains controversial. We performed an umbrella review of meta-analyses to summarize and evaluate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::331bad66361399cdd4fe65bcdd08cde5
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17843
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17843
Autor:
Gamerith G; Department of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria., Mildner F; Department of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria., Merkel PA; Division of Rheumatology and Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Harris K; Immune Tolerance Network (ITN), Bethesda, Maryland, USA., Cooney L; Immune Tolerance Network (ITN), Bethesda, Maryland, USA., Lim N; Immune Tolerance Network (ITN), Bethesda, Maryland, USA., Spiera R; Hospital for Special Surgery, New York City, New York, USA., Seo P; Department of Internal Medicine, Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA., Langford CA; Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Hoffman GS; Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, Ohio, USA., St Clair EW; Rheumatology, Duke University School of Medicine, Durham, North Carolina, USA., Fervenza FC; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA., Monach P; VA Boston Healthcare System, West Roxbury, Massachusetts, USA., Ytterberg SR; Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA., Geetha D; Division of Nephrology, Johns Hopkins University, Baltimore, Maryland, USA., Amann A; Department of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria., Wolf D; Department of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria., Specks U; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, New York, USA., Stone JH; Rheumatology Unit, Division of Rheumatology Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Kronbichler A; Department of Medicine, University of Cambridge, Cambridge, UK ak2283@cam.ac.uk.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2023 Feb; Vol. 82 (2), pp. 253-261. Date of Electronic Publication: 2022 Aug 16.
Autor:
Salcher S; Department of Internal Medicine V, Haematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria., Sturm G; Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria., Horvath L; Department of Internal Medicine V, Haematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria., Untergasser G; Department of Internal Medicine V, Haematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria., Kuempers C; Institute of Pathology, University of Luebeck and University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany., Fotakis G; Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria., Panizzolo E; Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria., Martowicz A; Department of Internal Medicine V, Haematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria; Tyrolpath Obrist Brunhuber GmbH, Zams, Austria., Trebo M; Department of Internal Medicine V, Haematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria., Pall G; Department of Internal Medicine V, Haematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria., Gamerith G; Department of Internal Medicine V, Haematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria., Sykora M; Department of Internal Medicine V, Haematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria., Augustin F; Department of Visceral, Transplant and Thoracic Surgery, Medical University Innsbruck, Innsbruck, Austria., Schmitz K; Tyrolpath Obrist Brunhuber GmbH, Zams, Austria; INNPATH GmbH, Institute of Pathology, Innsbruck, Austria., Finotello F; Institute of Molecular Biology, University of Innsbruck, Innsbruck, Austria; Digital Science Center, University of Innsbruck, Innsbruck, Austria., Rieder D; Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria., Perner S; Institute of Pathology, University of Luebeck and University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany; Pathology, Research Center Borstel, Leibniz Lung Center, Borstel, Germany; German Center for Lung Research (DZL), Luebeck and Borstel, Germany., Sopper S; Department of Internal Medicine V, Haematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria., Wolf D; Department of Internal Medicine V, Haematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria., Pircher A; Department of Internal Medicine V, Haematology & Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck, Innsbruck, Austria. Electronic address: andreas.pircher@i-med.ac.at., Trajanoski Z; Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: zlatko.trajanoski@i-med.ac.at.
Publikováno v:
Cancer cell [Cancer Cell] 2022 Dec 12; Vol. 40 (12), pp. 1503-1520.e8. Date of Electronic Publication: 2022 Nov 10.
Autor:
Gamerith G; Department of Haematology and Oncology, Clinic of Internal Medicine V, Medical University of Innsbruck, 6020 Innsbruck, Austria., Kloppenburg M; Clinic of Otorhinolaryngology-Head & Neck Surgery, Medical University of Innsbruck, 6020 Innsbruck, Austria., Mildner F; Department of Haematology and Oncology, Clinic of Internal Medicine V, Medical University of Innsbruck, 6020 Innsbruck, Austria., Amann A; Department of Haematology and Oncology, Clinic of Internal Medicine V, Medical University of Innsbruck, 6020 Innsbruck, Austria., Merkelbach-Bruse S; Institute of Pathology, University Hospital Cologne, 50937 Cologne, Germany., Heydt C; Institute of Pathology, University Hospital Cologne, 50937 Cologne, Germany., Siemanowski J; Institute of Pathology, University Hospital Cologne, 50937 Cologne, Germany., Buettner R; Institute of Pathology, University Hospital Cologne, 50937 Cologne, Germany., Fiegl M; Department of Haematology and Oncology, Clinic of Internal Medicine V, Medical University of Innsbruck, 6020 Innsbruck, Austria.; Clinic Hochrum, 6063 Rum, Austria., Manzl C; Institute of Pathology, Neuropathology and Molecularpathology, Medical University of Innsbruck, 6020 Innsbruck, Austria., Pall G; Department of Haematology and Oncology, Clinic of Internal Medicine V, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Oct 19; Vol. 14 (20). Date of Electronic Publication: 2022 Oct 19.